Charles Stephen Foster is an American ophthalmologist known for his research and treatment of ocular inflammatory disease (OID) with immunomodulatory therapy.
Foster established the Ocular Immunology and Uveitis Foundation to support relevant research.
[1] After his fellowship, Foster joined the full-time faculty in the Department of Ophthalmology at Harvard Medical School, serving as the director of the residency training program at MEEI.
[4] In 2005, he formed his own eye care facility, Massachusetts Eye Research and Surgery Institution (MERSI), and a foundation, the Ocular Immunology and Uveitis Foundation (OIUF)[1] Foster developed the "step ladder approach to care" for treating patients with ocular inflammatory disease.
This standard of care in treating uveitis/OID was published in July 2015 as the preferred practice patterns in the Journal of Survey of Ophthalmology.